H. Lundbeck A/S, a prominent Danish pharmaceutical company, has announced its largest-ever acquisition, agreeing to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion.

Motilal Oswal's research report has upgraded IPCA Laboratories to a "BUY" recommendation with a target price of Rs 1,950, an upside of 18% from its current market price of Rs 1,659.

Glenmark Pharmaceuticals Shares will be in focus today as the company has announced recall for two products in the US Market.

Gilead Sciences Inc.

Alembic Pharma share price is likely to see bullish activity after receiving a clean Form 483 with zero observations from the USFDA.

Zydus Lifesciences Share Price could see significant upside move as Sharekhan Research has suggested BUY Call considering strong fundamentals of the company.